Views: 954 Author: Site Editor Publish Time: 2026-06-02 Origin: Site
As the global pharmaceutical industry continues its dynamic transformation, one event consistently stands at the center of innovation, sourcing, and partnership building: CPHI China. This June, we are preparing to join thousands of industry professionals at the Shanghai New International Expo Centre for three days of meaningful connections and knowledge exchange.
CPHI & PMEC China 2026
June 16-18 | Shanghai International Expo Centre
Runxin Biotech — See you there
The numbers alone tell a compelling story: 240,000 square meters of exhibition space, 3,600+ exhibitors, and over 110,000 professional visitors from 150+ countries. But numbers only capture part of the picture.
What makes CPHI China irreplaceable is the quality of conversations that happen across those massive halls. When pharmaceutical manufacturers, API suppliers, formulators, and quality assurance professionals gather in one place, the exchange of knowledge accelerates in ways that virtual meetings simply cannot replicate.
For ingredient suppliers like Runxin Biotech, the show offers direct access to decision-makers who evaluate not just our products but our technical expertise, regulatory knowledge, and commitment to quality. These conversations shape partnerships that last years.
Runxin Biotech's presence at CPHI China reflects our commitment to serving the pharmaceutical, cosmetic, and nutraceutical industries with three complementary bioactive ingredients:
In pharmaceutical applications, pharmaceutical-grade sodium hyaluronate serves as a critical excipient and active ingredient. From ophthalmic viscosurgical devices protecting delicate eye tissues during cataract surgery to intra-articular injections supporting osteoarthritis treatment, the molecule's viscoelastic properties make it indispensable in formulations requiring precise rheological control.
In cosmetics and personal care, hyaluronic acid has become synonymous with hydration and anti-aging. European and North American brands increasingly seek suppliers who understand both cosmetic and pharmaceutical quality requirements—two standards that, while distinct, share common foundations in purity and consistency.
In nutraceuticals, oral hyaluronic acid for beauty-from-within and joint health applications continues growing, particularly in markets where consumers increasingly connect internal health with external appearance.
Chondroitin sulfate remains a cornerstone active pharmaceutical ingredient (API) for osteoarthritis treatments and a premium nutraceutical for joint health supplements. Our biofermentation-derived chondroitin sulfate offers advantages over traditional animal-derived sources: consistent molecular weight distribution, absence of animal pathogen concerns, and sustainable supply chains.
For pharmaceutical applications, chondroitin sulfate appears in finished dosage forms ranging from tablets to injectable solutions. Our documentation packages support regulatory submissions across multiple markets.
Glucosamine—whether as glucosamine sulfate, glucosamine hydrochloride, or N-acetyl-glucosamine—continues its established presence in joint health markets globally. Available in multiple crystalline forms and specifications, our glucosamine products serve both pharmaceutical and nutraceutical customers with consistent quality and regulatory compliance.
The combination market (glucosamine + chondroitin sulfate + hyaluronic acid) represents the fastest-growing segment, and our ability to supply all three ingredients from a single source offers meaningful supply chain advantages.
Runxin Biotech will be presenting our comprehensive range of products across multiple grades and specifications:
Pharmaceutical Grade: For ophthalmic applications, intra-articular injections, and advanced topical formulations requiring the strictest quality parameters. We understand that pharmaceutical buyers operate under different regulatory frameworks and expect documentation packages that facilitate their compliance processes.
Cosmetic Grade: For skincare, beauty supplements, and personal care applications where molecular weight consistency and purity profiles directly impact formulation performance.
Food Grade: For nutraceutical and functional food applications meeting relevant food safety standards across different market requirements.
Our team will be available to discuss:
· Customized molecular weight specifications for specific formulation requirements
· Regulatory documentation support for different market registrations
· Technical specifications, stability data, and certificate of analysis samples
· Flexible MOQ arrangements for emerging brands and established manufacturers
· Combined ingredient packages for "triple-action" joint health formulations
The 2026 CPHI China arrives at an interesting moment in global pharmaceutical supply chains. Data shows that China's pharmaceutical exports reached $91.1 billion in the first ten months of 2025 alone—a 3.52% increase year-over-year, outpacing overall trade growth significantly.
This growth reflects more than manufacturing capacity. It reflects the industry's increasing sophistication in quality management, regulatory compliance, and technical expertise. Chinese suppliers of hyaluronic acid, chondroitin sulfate, and glucosamine have invested substantially in fermentation technology, purification processes, and quality control systems that meet—or exceed—international pharmaceutical standards.
At Runxin Biotech, we've witnessed this evolution firsthand. Working with pharmaceutical customers globally requires understanding not just manufacturing processes but the regulatory frameworks of different markets, the documentation requirements of various pharmacopeias, and the quality expectations of sophisticated buyers.
Whether you're currently sourcing joint health ingredients, exploring alternative suppliers, or simply interested in understanding the current market landscape, we welcome your visit.
Our team looks forward to discussing your ingredient requirements, answering technical questions, and exploring how we might support your formulation development or product supply.
Runxin Biotech at CPHI China 2026
June 16-18
Shanghai New International Expo Centre
For those attending the show, feel free to reach out in advance to schedule a meeting. We're also happy to connect after the event for those whose schedules don't permit a visit to our booth.
See you in Shanghai.
Runxin Biotech specializes in pharmaceutical-grade, cosmetic-grade, and food-grade sodium hyaluronate, chondroitin sulfate, and glucosamine. Contact us to discuss your requirements or request technical documentation.
